<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00775957</url>
  </required_header>
  <id_info>
    <org_study_id>FLT-NHL</org_study_id>
    <nct_id>NCT00775957</nct_id>
  </id_info>
  <brief_title>Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma</brief_title>
  <official_title>Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgknin's Lymphoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oklahoma</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Midwest Medical Isotopes</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Oklahoma</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A study to determine the accuracy of FLT-PET in quantifying tumor cell proliferation at the
      initial staging of patients with Non-Hodgkin's Lymphoma in comparison wit the &quot;gold standard&quot;
      FDG-PET.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The first primary objective reflects a necessary and preliminary requirement: to reproduce
      published results and validate the use of FLT-PET. In this study, 35 patients will be
      selected to undergoing imaging with both FLT and FDG PET.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Terminated by institutional review board
  </why_stopped>
  <start_date>October 2008</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Staging and ReStaging scans</measure>
    <time_frame>after hematopoetic recovery</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Non-Hodgkin's Lymphoma</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>FLT-PET Scan</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>FDG-PET Scan</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>FLT-PET scan</intervention_name>
    <description>imaging scan</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>FDG-PET scan</intervention_name>
    <description>imaging scan</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects diagnosed with lymphoma and are about to start treatment with chemotherapy
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years or older

          -  Women must not be pregnant or breast feeding

          -  Histologic diagnosis of non-Hodgkin's lymphoma (any stage)

          -  Must undergo treatment with chemotherapy and/or radiotherapy

        Exclusion Criteria:

          -  May not have received previous therapy with radiopharmaceuticals

          -  May not have received prior therapy with cytotoxic chemotherapy and/or monoclonal
             antibodies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Oklahoma Health Sciences Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 17, 2008</study_first_submitted>
  <study_first_submitted_qc>October 17, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2008</study_first_posted>
  <last_update_submitted>September 27, 2010</last_update_submitted>
  <last_update_submitted_qc>September 27, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 28, 2010</last_update_posted>
  <responsible_party>
    <name_title>Jennifer Holter, MD</name_title>
    <organization>University of Oklahoma Health Sciences Center- Dept. of Medicine</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphoma</mesh_term>
    <mesh_term>Lymphoma, Non-Hodgkin</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

